Neuberger Berman Group LLC Bausch Health Companies Inc. Transaction History

Neuberger Berman Group LLC

$118 Billion
Q2 2024

A detailed history of Neuberger Berman Group LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 61,559 shares of BHC stock, worth $508,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,559

Previous 43,559 41.32%

Holding current value

$508,477

Previous $462,000 7.14%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.1 - $10.41 $109,800 - $187,380	18,000 Added 41.32%	61,559 $429,000
Q1 2024 May 13, 2024	BUY	$7.77 - $10.61 $338,453 - $462,160	43,559 New	43,559 $462,000
Q4 2023 Feb 09, 2024	SELL	$6.53 - $8.23 $65,561 - $82,629	-10,040 Reduced 9.52%	95,459 $765,000
Q2 2023 Aug 11, 2023	SELL	$5.72 - $8.8 $97,794 - $150,453	-17,097 Reduced 13.95%	105,499 $843,000
Q1 2023 May 12, 2023	BUY	$6.28 - $9.85 $10,368 - $16,262	1,651 Added 1.37%	122,596 $993,000
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $116,288 - $151,423	-19,095 Reduced 13.64%	120,945 $759,000
Q3 2022 Nov 15, 2022	BUY	$4.58 - $9.21 $166,574 - $334,967	36,370 Added 35.08%	140,040 $976,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $266,225 - $891,063	-37,709 Reduced 26.67%	103,670 $866,000
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $923,788 - $1.19 Million	42,768 Added 43.37%	141,379 $3.23 Million
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $25,714 - $32,433	-1,118 Reduced 1.12%	98,611 $2.72 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1.63 Million - $1.96 Million	-65,066 Reduced 39.48%	99,729 $2.78 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $574,356 - $684,705	-20,939 Reduced 11.27%	164,795 $4.84 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $1.46 Million - $2.35 Million	68,227 Added 58.06%	185,734 $5.9 Million
Q4 2020 Feb 10, 2021	BUY	$15.31 - $21.12 $479,386 - $661,309	31,312 Added 36.33%	117,507 $2.44 Million
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $469,047 - $634,537	-31,522 Reduced 26.78%	86,195 $1.34 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $290,344 - $447,405	21,814 Added 22.75%	117,717 $2.15 Million
Q1 2020 May 14, 2020	SELL	$12.98 - $30.25 $1.47 Million - $3.42 Million	-113,161 Reduced 54.13%	95,903 $1.49 Million
Q4 2019 Feb 12, 2020	BUY	$18.89 - $31.89 $3.95 Million - $6.67 Million	209,064 New	209,064 $6.26 Million
Q3 2019 Nov 13, 2019	SELL	$20.88 - $25.66 $420,335 - $516,561	-20,131 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $57,025 - $73,504	2,779 Added 16.02%	20,131 $508,000
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $12,239 - $15,905	605 Added 3.61%	17,352 $429,000
Q4 2018 Feb 12, 2019	SELL	$17.64 - $28.32 $102,858 - $165,133	-5,831 Reduced 25.83%	16,747 $311,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $466,009 - $579,577	22,578 New	22,578 $580,000

Others Institutions Holding BHC

# of Institutions

275

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Bausch Health Companies Inc. Transaction History